CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Regeneron Pharmaceuticals (NASDAQ: REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025
Portfolio Pulse from
A securities class action lawsuit has been filed against Regeneron Pharmaceuticals (NASDAQ: REGN) for alleged securities fraud. Investors who purchased Regeneron securities between November 2, 2023, and October 30, 2024, have until March 10, 2025, to seek lead plaintiff status.
March 05, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a securities fraud class action lawsuit. Investors who bought shares between November 2, 2023, and October 30, 2024, can join the lawsuit by March 10, 2025.
The filing of a securities fraud class action lawsuit against Regeneron is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for investors to join the lawsuit is March 10, 2025.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100